J&J nears deal for Aspen to make its own Covid-19 vaccine for Africa
Johnson & Johnson and Aspen Pharmacare Holdings Ltd have agreed on terms that may lead to a licensing deal allowing the SA drug company to make its own-branded Covid-19 vaccine and decide on the recipients of the doses it produces.
Source: timeslive.co.za